Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

6.74
Delayed Data
As of Jan 18
 +0.04 / +0.60%
Today’s Change
4.50
Today|||52-Week Range
11.69
-2.88%
Year-to-Date
More Innovation, Less Regulation: 2 Biotech Stocks That Could Soar in 2017
Jan 11 / MotleyFool.com - Paid Partner Content
How Risky Is Inovio Pharmaceuticals, Inc.?
Jan 05 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close6.70
Today’s open6.70
Day’s range6.60 - 6.77
Volume555,743
Average volume (3 months)1,056,391
Market cap$496.2M
Dividend yield--
Data as of 4:00pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)+31.25%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+288.00%
P/E ratioNM
Price/Sales11.32
Price/Book2.75

Competitors

 Today’s
change
Today’s
% change
RETAReata Pharmaceutical...+0.47+2.09%
HRTXHeron Therapeutics I...-0.05-0.39%
PTCTPTC Therapeutics Inc-0.29-1.97%
OTICOtonomy Inc-0.25-1.57%
Data as of 4:00pm ET, 01/18/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$40.6M
Annual profit (last year)-$29.2M
Net profit margin-71.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts


Search for Jobs